The weakness in sensitivity-specificity of various guaiac tests in the detection of faecal occult blood is well recognised.'2 If adapted to a more sensitive level, false positives prevail, if made insensitive to avoid that, a substantial number of bleedings are missed. Another weakness is the common acceptance of visual interpretations of qualitative colour tests.
The problem can be approached in another way. By adjusting the guaiac test to its most sensitive level, all significant bleedings will be included, as well as the false positive cases. 3 To differentiate these, a second test is used, a specific immunochemical determination of human haemoglobin. 4 Particularly important is that the test is a quantitative colorimetric determination and is easy to reproduce.
In a pilot experiment on a small population (unpublished data) it appeared that by utilising the whole scale of sensitivity of the quantitative immunotest, a group of bleeders was detected including mainly benign conditions and physiological diffusion leakage. This being especially true in the lower 0-20-039 absorbance level of the immunotest. With all these eliminating measures -that is, after a primary screening with a sensitive guaiac test, a raised lower limit in the evaluation of the final immunotest, and the clearing up of anal tract bleedings, we had to carry out a colonoscopy in 174 cases (2.5% of the participants). In 46 cases where colonoscopy was not completed, a double contrasted barium enema was used. Table 2 illustrates the histological diagnosis, and the size and bleeding tendency of the tumours. Seven adenocarcinomas, 44 adenomas of various histological structures, and four hyperplastic polyps were found, 55 tumours altogether. These figures represent numbers of people. In six instances where two to three adenomas were present simultaneously, the biggest and that most evidently bleeding was counted. In endoscopical evaluation of the bleeding tendency of the tumour, 48 tumours were evidently bleeding whereas in seven cases bleeding was not apparent. Table 3 shows the absorbance figures in tumour cases. The Table also gives the distance of the tumour from the anus. Evidently, most tumour cases are above the 0.80 absorbance level, among them all tumours situated more than 60 cm from the anus. Only 12 tumours gave a lower absorbance between 0-40 and 0-70. In the total group of over 0-40 absorbance bleeders, 340 persons, 178 (2.6%) were in the 0-40-0-80 level.
Discussion
A Danish faecal occult blood screening has been carried out recently on the island of Funen.6 This study also covered an unselected population, and a similar age group to ours. The acceptability in these differed only slightly, 66 5% in our study and 69% in Denmark. It should be noted that in our study no reminders were used. In assessing the likely acceptability rates for similar screenings in the future we have to bear in mind that this was the first screening of its kind in this country. The population had no knowledge of the procedure nor of its usefulness.
The new double test Fecatwin S -FECA-EIA was now used for the first time in our country in an extensive screening for faecal occult blood. Fecatwin S yielded 54-1% of positives in the population. This despite asking the participants to follow dietary restrictions. The figure is higher than expected. Whether the sensitive guaiac test is needed at all is a question of economics. Immunotests are more costly, and excluding 46% of the population by using the inexpensive guaiac test is cost effective. Reanalysis of these 3719 guaiac positive samples by means of the immunochemical human haemoglobin test (FECA-EIA) yielded 7-7% of positives of over 0-20 absorbance. The lower limit of positivity for introduction of any further clinical examinations, however, was primarily set to the 0.40 absorbance level. In this way only 4.9% of the participants needed clinical examinations. In our earlier unpublished study the clinical examinations of the group of low positives (0.20-0 39 absorbance level) revealed no tumours in total 61 instances. This strongly justifies changing the lower limit of positivity. To clarify the fate of the group of low-positives in this study, 186 persons, a secondary faecal sample was taken after half a year's delay. This was intended only to reveal whether any of the subjects showed progression in their bleeding tendency. This was the case in only 25 instances. We are fully aware that the real fate of this group could be elucidated only by clinically examining them as was done in earlier studies' and our unpublished study.
Further reduction of the number ofcolonoscopies was achieved when benign anal tract bleedings were revealed by means of a very careful clinical interview. Eliminating the apparent first source of bleeding by treatment cleared up the source of bleeding in 149 cases. In 56 cases further bleeding was observed, and the possibility of an upper source was apparent. Thus the total of 174 cases (2.5% of the participants) remained for colonoscopy.
Typical of these anal tract bleedings was a lower absorbance level, below 0-80 in over half of the cases. On the other hand, in the group which showed continuous positivity after treatment of benign anal tract bleedings, over half of the cases belonged to fhe over 0-80 absorbance group. All the 12 tumours detected behind the piles showed bleeding of over 0-80 absorbance. A majority of tumour cases showed an absorbance over 0.80 (Table 3) . If the limit of positivity were set at the 0-80 absorbance level, the number of positives would be reduced from 340 by 178, and the number of endoscopies would decline to about 1%, without essentially missing tumour cases. A larger scale study is needed, however, to confirm the above suggestion.
Our results indicate that slightly bleeding tumours are rare. When they bleed, they give a sufficient amount of blood to get out the destructive milieu in the gut, and for a specific Hb-test to detect it. In cases where the tumour is not bleeding this principle of screening does not function at all. The total number of findings in our study indicates, however, that a substantial proportion of colorectal tumours probably bleed. Certainty can be assured only by carrying out colonoscopies on the whole population under investigation. An intermittent bleeding can cause a false negative result in the group of originally negatives as well. Ultimately the problem is how often to rescreen the actual population. This is, however, outside of the scope of the present study.
As this study was carried out among an unselected population, the 
